Friday June 23rd 2017

Archive for October, 2012

Canadian study tracks MS patients after ‘liberation treatment’

Canadian study tracks MS patients after ‘liberation treatment’

A Canadian study that tracked 80 multiple sclerosis patients who underwent the controversial “liberation treatment” outside of the country suggests that about half of them saw their symptoms improve after the procedure. Researchers in British Columbia surveyed 80 people [Read More]

MS patients don’t have years to wait for studies

MS patients don’t have years to wait for studies

Like all of those suffering from MS, or with a loved one with MS, I have been following the latest news with interest. Once again, the bait of possible liberation treatment availability in this province/country is dangled in front of our noses, and once again my phone is [Read More]

Finally, CCSVI clinical trials. So why is everyone so pissed off?

Finally, CCSVI clinical trials. So why is everyone so pissed off?

On Friday, the Canadian government announced approval of clinical trials into the safety and efficacy of treatment for cerebrospinal venous insufficiency, better known as CCSVI. Health Minister Leona Aglukkaq broke the news at a health ministers’ meeting more than five [Read More]

Latest Topics

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]

MS Society Disappointed with Senate Healthcare Bill

MS Society Disappointed with Senate Healthcare Bill

/About-the-Society/News/HealthcareBill-6-22 [Read More]

Type I interferons could have role in natural improvement of RA during pregnancy

Type I interferons could have role in natural improvement of RA during pregnancy

An international US-Danish team of scientists, led by Damini Jawaheer, Ph.D. at the UCSF Benioff Children's Hospital [Read More]

Shared decision-making essential to optimal treatment and quality of life for patients with MS

Shared decision-making essential to optimal treatment and quality of life for patients with MS

One of the cornerstones of multiple sclerosis treatment is shared decision-making between patients and their doctors [Read More]

UC consortium formed to speed up development of new drugs

UC consortium formed to speed up development of new drugs

For 12 years, UCLA researcher Dennis Slamon pursued a groundbreaking approach to treating breast cancer: Attack the [Read More]